Biocept, Inc. (BIOC) CEO Michael Nall on Q1 2021 Results - Earnings Call Transcript

May 12, 2021 7:10 PM ETBiocept, Inc. (BIOCQ) StockBIOCQ
SA Transcripts
153.96K Followers

Q1: 2021-05-12 Earnings Summary

EPS of $5.70 beats by $5.70

Biocept, Inc. (BIOC) Q1 2021 Earnings Conference Call May 13, 2021 4:30 PM ET

Company Participants

Jody Cain - LHA
Michael Nall - CEO, President & Director
Tim Kennedy - CFO, SVP, Operations & Corporate Secretary
Michael Dugan - SVP, Chief Medical Officer & Medical Director

Conference Call Participants

Michael Okunewitch - Maxim Group

Operator

Good day, and welcome to the Biocept First Quarter Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.

I would now like to turn the conference over to Jody Cain. Please go ahead.

Jody Cain

This is Jody Cain with LHA. Thank you all for participating in today's conference call. Joining me from Biocept are Michael Nall, President and Chief Executive Officer and Tim Kennedy, Chief Operating Officer and Chief Financial Officer

During this call, management will be making a number of forward-looking statements within the meaning of the private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts and generally can be identified by terms such as anticipates, estimates, believes, could, expects, intends, may, plans, potential, predicts, projects, should, will, would or the negative of those terms. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those statements, as well as performance or achievements that are implied by the forward-looking statements.

In particular, there is significant uncertainty about the duration, severity and impact of the COVID-19 pandemic. This means results could change at any time and the contemplated impact of COVID-19 on Biocept's operations, financial results and outlook is the best estimate based on the information for today's discussion.

Recommended For You

About BIOCQ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on BIOCQ